4
2
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2558 |
Cladribine
2-chlorodeoxyadenosine,克拉屈滨,2-Chloro-2′-deoxyadenosine,CldAdo,2CdA |
Apoptosis; Adenosine deaminase | Apoptosis; Metabolism |
Cladribine (2CdA) 是一种嘌呤核苷类似物,是具有口服活性的腺苷脱氨酶抑制剂。它能作为 DNA 合成的抑制剂,可阻断受损 DNA 的修复。它可抑制 DNA 甲基化,具有抗淋巴瘤活性,可研究血液恶性肿瘤和多发性硬化。 | |||
T76693 |
Moxetumomab
|
ADC Antibody | Antibody-drug Conjugate/ADC Related |
Moxetumomab 是一种靶向重组CD22的免疫毒素。可用于研究毛细胞白血病 (HCL)。 | |||
T34322 |
Rhynchotechol
|
Others | Others |
Rhynchotechol 是一种蒽醌类化合物。它从毛线柱苣苔中分离得到,这种植物主要分布在中国云南省南部,一直被用作治疗肝炎的民间药物。 | |||
T76783 |
Moxetumomab pasudotox
|
Others; Antibody-Drug Conjugates (ADCs) | Antibody-drug Conjugate/ADC Related; Others |
Moxetumomab pasudotox (CAT 8015) 是一种抗CD22免疫毒素,含有抗CD22Fv 和Pseudomonas exotoxin。CD22是在多种恶性 B 细胞上表达的细胞表面受体。Moxetumomab pasudotox 可用于毛细胞白血病 (HCL) 的研究。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN5445 |
Isowighteone
4',5,7-Trihydroxy-3'-prenylisoflavone |
||
Isowighteone, a compound that is not naturally produced in this species, accumulated by medicago truncatula hairy roots expressing LaPT1, indicates a strategy for metabolic engineering of novel antimicrobial compounds in legumes; it may have antimicrobial | |||
T81987 |
Kanzonol D
|
||
Kanzonol D为一种存在于Glycyrrhiza glabra的毛状根培养物中的类黄酮化合物。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPJ-00766 |
ANXA1 Protein, Human, Recombinant
Chromobindin-9,Phospholipase A2 Inhibitory Protein,Annexin-1... |
Human | E. coli |
Annexin A1 is the first characterized member of the annexin family of proteins and is able to bind to cellular membranes in a calcium-dependent manner, promoting membrane fusion and endocytosis. Annexin A1 has anti-inflammatory properties and inhibits phospholipase A2 activity. Annexin A1 also has roles in many diverse cellular functions, such as membrane aggregation, inflammation, phagocytosis, proliferation, apoptosis, and tumorigenesis and cancer development. ANXA1 is strongly expressed on th... |